| Product Code: ETC4694549 | Publication Date: Nov 2023 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Israel radiopharmaceutical market is thriving, propelled by the country`s strong emphasis on nuclear medicine and its applications in diagnosis and treatment. Radiopharmaceuticals are crucial in imaging and therapy for various medical conditions, including cancer and cardiovascular diseases. The market benefits from a well-established healthcare infrastructure, continuous R&D, and collaborations with global pharmaceutical companies, fostering innovation and market growth.
The radiopharmaceutical market in Israel is driven by the expanding applications of nuclear medicine in diagnosis and therapy. Innovations in targeted cancer treatments and the increasing use of PET and SPECT scans contribute to the demand for radiopharmaceuticals. Additionally, investments in healthcare infrastructure and research into new radiopharmaceutical compounds enhance the market`s growth potential.
The Radiopharmaceutical market in Israel faces challenges related to the complex regulatory environment and the high cost of development and production. Securing consistent supply chains for radioactive materials and ensuring the safety and efficacy of products are ongoing issues. Additionally, the market must contend with limited reimbursement policies and the need for specialized logistics for product distribution.
The Israel government actively promotes the radiopharmaceutical market through supportive regulations and funding for research and development. The Ministry of Health regulates the production and use of radiopharmaceuticals, ensuring they meet safety and efficacy standards. Policies also encourage collaboration between research institutions and the pharmaceutical industry.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Radiopharmaceutical Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Radiopharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Radiopharmaceutical Market - Industry Life Cycle |
3.4 Israel Radiopharmaceutical Market - Porter's Five Forces |
3.5 Israel Radiopharmaceutical Market Revenues & Volume Share Segmentations, 2021 & 2031F |
3.6 Israel Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Israel Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2021 & 2031F |
3.8 Israel Radiopharmaceutical Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Israel Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Israel Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Radiopharmaceutical Market Trends |
6 Israel Radiopharmaceutical Market Segmentations |
6.1 Israel Radiopharmaceutical Market Segmentations |
6.1.1 Overview and Analysis |
6.1.2 Israel Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.3 Israel Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.2 Israel Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Israel Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.2.3 Israel Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2021-2031F |
6.3 Israel Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Israel Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Israel Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
6.4 Israel Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Israel Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2021-2031F |
6.4.3 Israel Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2021-2031F |
6.5 Israel Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Israel Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.3 Israel Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.5.4 Israel Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2021-2031F |
6.5.5 Israel Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2021-2031F |
6.5.6 Israel Radiopharmaceutical Market Revenues & Volume, By Others, 2021-2031F |
7 Israel Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Israel Radiopharmaceutical Market Export to Major Countries |
7.2 Israel Radiopharmaceutical Market Imports from Major Countries |
8 Israel Radiopharmaceutical Market Key Performance Indicators |
9 Israel Radiopharmaceutical Market - Opportunity Assessment |
9.1 Israel Radiopharmaceutical Market Opportunity Assessment Segmentations, 2021 & 2031F |
9.2 Israel Radiopharmaceutical Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Israel Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2021 & 2031F |
9.4 Israel Radiopharmaceutical Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Israel Radiopharmaceutical Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Israel Radiopharmaceutical Market - Competitive Landscape |
10.1 Israel Radiopharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Israel Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here